Kevetrin: Phase I start

In August, Cellceutix will begin a U.S. Phase I trial to evaluate Kevetrin. In March, Cellceutix partnered with Beth Israel Deaconess Medical Center (Boston, Mass.) to research Kevetrin to treat mela...